Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it?

被引:10
|
作者
Damania, Blossom [1 ,2 ]
Dittmer, Dirk P. [1 ,2 ]
机构
[1] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC USA
[2] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Sch Med, Dept Microbiol & Immunol, 450 West Dr CB 7295,Rm 12-048, Chapel Hill, NC 27599 USA
关键词
herpesvirus; Kaposi sarcoma; KSHV; PRIMARY EFFUSION LYMPHOMA; PEGYLATED-LIPOSOMAL DOXORUBICIN; MULTICENTRIC CASTLEMAN DISEASE; INFLAMMATORY CYTOKINE SYNDROME; BLOOD MONONUCLEAR-CELLS; HIV-NEGATIVE MEN; DNA-SEQUENCES; ENDOTHELIAL-CELLS; GENE-EXPRESSION; C-MYC;
D O I
10.1002/jmv.28773
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This review will provide an overview of the notion that Kaposi sarcoma (KS) is a disease that manifests under diverse and divergent circumstances. We begin with a historical introduction of KS and KS-associated herpesvirus (KSHV), highlight the diversity of clinical presentations of KS, summarize what we know about the cell of origin for this tumor, explore KSHV viral load as a potential biomarker for acute KSHV infections and KS-associated complications, and discuss immune modulators that impact KSHV infection, KSHV persistence, and KS disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Kaposi's Sarcoma Herpesvirus Upregulates Aurora A Expression to Promote p53 Phosphorylation and Ubiquitylation
    Cai, Qiliang
    Xiao, Bingyi
    Si, Huaxin
    Cervini, Amanda
    Gao, Jianming
    Lu, Jie
    Upadhyay, Santosh K.
    Verma, Suhbash C.
    Robertson, Erle S.
    PLOS PATHOGENS, 2012, 8 (03) : e1002566
  • [32] Kaposi's sarcoma herpesvirus-induced endothelial cell reprogramming supports viral persistence and contributes to Kaposi's sarcoma tumorigenesis
    Gramolelli, Silvia
    Ojala, Paivi M.
    CURRENT OPINION IN VIROLOGY, 2017, 26 : 156 - 162
  • [33] Positive staining of tumor-stage Kaposi sarcoma with lymphatic marker D2-40
    Dubina, Meghan
    Goldenberg, Gary
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 61 (02) : 276 - 280
  • [34] Inhibition of lytic reactivation of Kaposi's sarcoma-associated herpesvirus by alloferon
    Lee, Naeun
    Bae, Seyeon
    Kim, Hyemin
    Kong, Joo Myung
    Kim, Hang-Rae
    Cho, Byung Joo
    Kim, Sung Joon
    Seok, Seung Hyeok
    Hwang, Young-il
    Kim, Sooin
    Kang, Jae Seung
    Lee, Wang Jae
    ANTIVIRAL THERAPY, 2011, 16 (01) : 17 - 26
  • [35] Arachidonic Acid Derived Lipid Mediators Influence Kaposi's Sarcoma-Associated Herpesvirus Infection and Pathogenesis
    Chandrasekharan, Jayashree A.
    Sharma-Walia, Neelam
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [36] Role of Host MicroRNAs in Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis
    Qin, Zhiqiang
    Peruzzi, Francesca
    Reiss, Krzysztof
    Dai, Lu
    VIRUSES-BASEL, 2014, 6 (11): : 4571 - 4580
  • [37] Kaposi's Sarcoma Herpesvirus MicroRNAs Induce Metabolic Transformation of Infected Cells
    Yogev, Ohad
    Lagos, Dimitris
    Enver, Tariq
    Boshoff, Chris
    PLOS PATHOGENS, 2014, 10 (09)
  • [38] Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Is Independent of Anaphase-Promoting Complex Activity
    Elbasani, Endrit
    Gramolelli, Silvia
    Gunther, Thomas
    Gabaev, Ildar
    Grundhoff, Adam
    Ojala, Paivi M.
    JOURNAL OF VIROLOGY, 2020, 94 (13)
  • [39] Instigation of Notch signaling in the pathogenesis of Kaposi's sarcoma-associated herpesvirus and other human tumor viruses
    Cheng, Fang
    Pekkonen, Pirita
    Ojala, Paivi M.
    FUTURE MICROBIOLOGY, 2012, 7 (10) : 1191 - 1205
  • [40] Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi's Sarcoma-Associated Herpesvirus
    Schifano, Jason M.
    Corcoran, Kathleen
    Kelkar, Hemant
    Dittmer, Dirk P.
    JOURNAL OF VIROLOGY, 2017, 91 (04)